181 related articles for article (PubMed ID: 12168750)
1. Comparative mycobacterial genomics as a tool for drug target and antigen discovery.
Cole ST
Eur Respir J Suppl; 2002 Jul; 36():78s-86s. PubMed ID: 12168750
[TBL] [Abstract][Full Text] [Related]
2. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
3. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
4. targetTB: a target identification pipeline for Mycobacterium tuberculosis through an interactome, reactome and genome-scale structural analysis.
Raman K; Yeturu K; Chandra N
BMC Syst Biol; 2008 Dec; 2():109. PubMed ID: 19099550
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive essentiality analysis of the
Levendosky K; Janisch N; Quadri LEN
mBio; 2023 Aug; 14(4):e0057323. PubMed ID: 37350613
[No Abstract] [Full Text] [Related]
6. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
Tomioka H
Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
[TBL] [Abstract][Full Text] [Related]
7. Structural genomics of Mycobacterium tuberculosis: a preliminary report of progress at UCLA.
Goulding CW; Perry LJ; Anderson D; Sawaya MR; Cascio D; Apostol MI; Chan S; Parseghian A; Wang SS; Wu Y; Cassano V; Gill HS; Eisenberg D
Biophys Chem; 2003 Sep; 105(2-3):361-70. PubMed ID: 14499904
[TBL] [Abstract][Full Text] [Related]
8. [Recent progress in mycobacteriology].
Okada M; Kobayashi K
Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
[TBL] [Abstract][Full Text] [Related]
9. Comparative genomics of the mycobacteria.
Brosch R; Gordon SV; Pym A; Eiglmeier K; Garnier T; Cole ST
Int J Med Microbiol; 2000 May; 290(2):143-52. PubMed ID: 11045919
[TBL] [Abstract][Full Text] [Related]
10. Genomic insights into tuberculosis.
Galagan JE
Nat Rev Genet; 2014 May; 15(5):307-20. PubMed ID: 24662221
[TBL] [Abstract][Full Text] [Related]
11. Genomewide Assessment of Mycobacterium tuberculosis Conditionally Essential Metabolic Pathways.
Minato Y; Gohl DM; Thiede JM; Chacón JM; Harcombe WR; Maruyama F; Baughn AD
mSystems; 2019 Jun; 4(4):. PubMed ID: 31239393
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of potential druggable targets among hypothetical proteins of extensively drug resistant Mycobacterium tuberculosis (XDR KZN 605) through subtractive genomics approach.
Uddin R; Siddiqui QN; Azam SS; Saima B; Wadood A
Eur J Pharm Sci; 2018 Mar; 114():13-23. PubMed ID: 29174549
[TBL] [Abstract][Full Text] [Related]
13. Royal Society of Tropical Medicine and Hygiene Meeting at Manson House, London, 18th January 2001. Pathogen genomes and human health. Mycobacterial genomics.
Gordon SV; Brosch R; Eiglmeier K; Garnier T; Hewinson RG; Cole ST
Trans R Soc Trop Med Hyg; 2002; 96(1):1-6. PubMed ID: 11925980
[TBL] [Abstract][Full Text] [Related]
14. T-iDT : tool for identification of drug target in bacteria and validation by Mycobacterium tuberculosis.
Singh NK; Selvam SM; Chakravarthy P
In Silico Biol; 2006; 6(6):485-93. PubMed ID: 17518759
[TBL] [Abstract][Full Text] [Related]
15. Application of a subtractive genomics approach for in silico identification and characterization of novel drug targets in Mycobacterium tuberculosis F11.
Hosen MI; Tanmoy AM; Mahbuba DA; Salma U; Nazim M; Islam MT; Akhteruzzaman S
Interdiscip Sci; 2014 Mar; 6(1):48-56. PubMed ID: 24464704
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic and genomic comparison of Mycobacterium aurum and surrogate model species to Mycobacterium tuberculosis: implications for drug discovery.
Namouchi A; Cimino M; Favre-Rochex S; Charles P; Gicquel B
BMC Genomics; 2017 Jul; 18(1):530. PubMed ID: 28705154
[TBL] [Abstract][Full Text] [Related]
17. Pathogenicity in the tubercle bacillus: molecular and evolutionary determinants.
Gordon SV; Bottai D; Simeone R; Stinear TP; Brosch R
Bioessays; 2009 Apr; 31(4):378-88. PubMed ID: 19274661
[TBL] [Abstract][Full Text] [Related]
18. Exploring functional genomics for the development of novel intervention strategies against tuberculosis.
Rachman H; Kaufmann SH
Int J Med Microbiol; 2007 Nov; 297(7-8):559-67. PubMed ID: 17467338
[TBL] [Abstract][Full Text] [Related]
19. Comparative genomics of mycobacteria: some answers, yet more new questions.
Behr MA
Cold Spring Harb Perspect Med; 2014 Nov; 5(2):a021204. PubMed ID: 25395374
[TBL] [Abstract][Full Text] [Related]
20. [Prospects for development of new antituberculous drugs].
Tomioka H
Kekkaku; 2002 Aug; 77(8):573-84. PubMed ID: 12235850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
